Could a common antioxidant help newborns fight deadly sepsis?
NCT ID NCT07380347
First seen Feb 02, 2026 · Last updated Apr 29, 2026 · Updated 11 times
Summary
This study tests whether adding N-acetylcysteine (NAC) to standard care helps newborns with sepsis recover faster. Sepsis causes dangerous inflammation and cell damage, partly due to oxidative stress. NAC may reduce that damage. The trial will enroll 50 near-term and full-term infants up to 28 days old with confirmed sepsis, measuring changes in organ function, oxidative stress markers, hospital stay length, and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.